NCT00901407 - Lamotrigine Augmentation in Resistant Depression | Biotech Hunter

Enrollment

138

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

April 30, 2007

Conditions

Unipolar Depression

Interventions

DRUG

lamotrigine

lamotrigine augmentation 25 to 100 mg tablets, 25 to 200 mg bid,10 weeks

DRUG

placebo

placebo: 1-2 tablets bid; 10 weeks

DRUG

paroxetine

open label paroxetine 10 to 50 mg, at bedtime for 18 weeks (8 weeks prior to randomization and 10 weeks after)

Trial Locations (1)

LSUHSC- New Orleans, New Orleans